FOXP3 as a prognostic marker and therapeutic target in immunogenic cell death modulation for clear cell renal cell carcinoma
Abstract Background Clear cell renal cell carcinoma (ccRCC) remains a challenging cancer type due to its resistance to standard treatments. Immunogenic cell death (ICD) has the potential to activate anti-tumor immunity, presenting a promising avenue for ccRCC therapies. Methods We analyzed data from...
Saved in:
Main Authors: | Jian Chen, Cheng Zhu, Yan He, Liping Huang, Weizhuo Wang, Shuaishuai Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-025-01831-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of a novel immunogenic cell death-related classifier to predict prognosis and optimize precision treatment in hepatocellular carcinoma
by: Dongjing Zhang, et al.
Published: (2025-01-01) -
Bladder Metastasis from Clear Cell Renal Cell Carcinoma: A Case Report
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01) -
Silver nanoparticle induced immunogenic cell death can improve immunotherapy
by: Ara Sargsian, et al.
Published: (2024-11-01) -
Machine learning identification of a novel vasculogenic mimicry-related signature and FOXM1’s role in promoting vasculogenic mimicry in clear cell renal cell carcinoma
by: Chao Xu, et al.
Published: (2025-03-01) -
Clinical significance and pro-oncogenic function of DBF4 in clear cell renal cell carcinoma
by: Liuyan Chen, et al.
Published: (2025-01-01)